Eli Lilly

4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package
Motley Fool
Wed, 03/17/21 - 10:39 am
stimulus
pharma stocks
Eli Lilly
Merck
Jazz Pharmaceuticals
AbbVie
Eli Lilly, Novartis back a biotech startup boasting 'best of both worlds' protein degraders
Endpoints
Wed, 03/17/21 - 10:30 am
Eli Lilly
Novartis
protein degradation
Amphista
Lilly's Skyrizi rival hits goal in ulcerative colitis phase 3, as it ups the ante against AbbVie
Fierce Biotech
Tue, 03/16/21 - 10:56 am
Eli Lilly
clinical trials
mirikizumab
ulcerative colitis
Lilly lays out 2-year plan to gain approval for Alzheimer's drug
BioPharma Dive
Tue, 03/16/21 - 12:04 am
Eli Lilly
donanemab
clinical trials
Alzheimer's disease
Why Eli Lilly's Successful Alzheimer's Disease Study Was So Disappointing
Motley Fool
Mon, 03/15/21 - 11:03 am
Eli Lilly
Alzheimer's disease
clinical trials
donanemab
Insider alleges Eli Lilly blocked her efforts to sound alarms about U.S. drug factory
Reuters
Sun, 03/14/21 - 11:03 pm
Eli Lilly
drug manufacturing
Trulicity
Lilly rejoins KRAS race with swipe at Amgen and Mirati, plans 2021 clinical trial
Fierce Biotech
Thu, 03/11/21 - 10:47 am
Eli Lilly
KRAS
Amgen
Mirati Therapeutics
LY3499446
solid tumors
Lilly lines up its next shot at Alzheimer’s
EP Vantage
Thu, 03/11/21 - 10:39 am
Eli Lilly
donanemab
Alzheimer's disease
Eli Lilly COVID-19 antibody combo aces study, cutting hospitalizations and deaths by a whopping 87%
Fierce Pharma
Wed, 03/10/21 - 11:24 am
Eli Lilly
antibodies
FDA
bamlanivimab-etesevimab
COVID-19
Lilly, Biolojic to develop antibody therapies for diabetes treatment
Pharmaceutical Business Review
Tue, 03/9/21 - 10:33 am
Eli Lilly
Biolojic Design
diabetes
R&D
AI uncovers Eli Lilly's rheumatoid arthritis drug Olumiant as potential Alzheimer's treatment
Fierce Biotech
Mon, 03/8/21 - 10:42 am
Eli Lilly
olumiant
JAK inhibitors
artificial intelligence
Alzheimer's disease
Lilly has its Ozempic-beating data from a head-to-head diabetes trial. Should Novo Nordisk be worried?
Fierce Pharma
Sun, 03/7/21 - 01:27 pm
Eli Lilly
tirzepatide
diabetes
Ozempic
Novo Nordisk
clinical trials
Lilly's tirzepatide beats Novo's semaglutide in diabetes phase 3, but another study muddies picture
Fierce Biotech
Thu, 03/4/21 - 10:05 am
Eli Lilly
Novo Nordisk
tirzepatide
semaglutide
type 2 diabetes
clinical trials
Eli Lilly, Incyte Report Positive Results For Baricitinib In Alopecia Areata Treatment
NASDAQ
Wed, 03/3/21 - 10:53 am
Eli Lilly
Incyte
baricitinib
alopecia areata
Look for Eli Lilly's Verzenio to hit $4.6B, thanks to early breast cancer win: analyst
Fierce Pharma
Tue, 03/2/21 - 12:12 pm
Eli Lilly
Verzenio
breast cancer
early breast cancer
Lilly scores $210M supply deal for newly authorized coronavirus antibody cocktail
Fierce Pharma
Sun, 02/28/21 - 11:56 pm
Eli Lilly
antibodies
COVID-19
government contract
Merck inks $1.9B Pandion takeover to square up against Amgen, Lilly and Roche
Fierce Biotech
Thu, 02/25/21 - 10:44 am
Merck
Pandion
M&A
immune modulators
Amgen
Eli Lilly
Roche
Watch out, Novo Nordisk. Lilly's new dual action diabetes med could pressure Ozempic: analyst
Fierce Pharma
Tue, 02/23/21 - 10:56 pm
Eli Lilly
tirzepatide
Novo Nordisk
Ozempic
diabetes
Eli Lilly's David Ricks snared $24M pay package in a year turbo-boosted by Covid-19 antibody
Endpoints
Mon, 02/22/21 - 10:47 am
Eli Lilly
David Ricks
executive pay
Pharma CEOs
pandemic
COVID-19
Lilly wagers almost $1B on Rigel's drugs for immune and nervous systems
BioPharma Dive
Thu, 02/18/21 - 10:05 pm
Eli Lilly
Rigel Pharmaceuticals
autoimmune disease
inflammatory disease

Pages